by Eric Christianson | May 22, 2019 | Medication and Disease State Clinical Pearls For Pharmacists, Psychiatry and Addiction Medication and Disease State Clinical Pearls
I was recently reviewing some clinical pearls on clozapine and was really surprised that there were five boxed warnings! After reading them over, I did recall all of the potential negative adverse effects that this drug can cause but did not remember that they were...
by Eric Christianson | May 15, 2019 | Medication and Disease State Clinical Pearls For Pharmacists, Neurology, Pain, and Musculoskeletal Medication and Disease State Clinical Pearls
Working in geriatrics, you get an appreciation (unfortunately) for how devastating the disease can be. Medications play a significant role in dementia as well as how they are utilized. Here are 5 common medication concerns in dementia that I have seen in my practice...
by Eric Christianson | May 8, 2019 | Medication and Disease State Clinical Pearls For Pharmacists, Neurology, Pain, and Musculoskeletal Medication and Disease State Clinical Pearls
Parkinson’s is one of the most complex disease states you will encounter. Whenever you talk about a disease of the brain and nervous system, you know that we likely don’t have a 100% clear understanding of how it works and why it happens. However, we...
by Eric Christianson | May 5, 2019 | Polypharmacy Cases And The Prescribing Cascade
In long term care consulting, learning how to review and interpret medical records is an absolute must. It can also be incredibly helpful in other settings such as ambulatory care, community, assisted living, and hospital pharmacy. I’ve got three examples for...
by Eric Christianson | May 1, 2019 | Drug Interaction Case Studies and Education For Pharmacists
One of the big advantages of newer agents like rivaroxaban is there’s less potential for diet and drug interactions than with warfarin. Now that doesn’t mean that there aren’t any rivaroxaban drug interactions. We have to pay attention to these...
